Category Archives: Events
Oakwood Labs is happy to announce that we will be exhibiting and speaking at the upcoming American Association of Pharmaceutical Scientists (AAPS) 2025 PharmaSci 360 event. The event is from November 9-12 at the Henry B. Gonzalez Convention Center in San Antonio, Texas. If you would like to learn more about the event, please visit the following link: https://aaps2025.eventscribe.net/index.asp
- Presentation from Rachel Minrovic (Formulations) during the Chalk Talk on Spotlight Stage C, Aisle 3800, in the Exhibit Hall from 9:30am to 10:15am on Tuesday, November 11th
- Exhibiting at booth #3629. Stop by to meet our business and technical team.
Company Overview
Oakwood Labs is a global leading CDMO in sustained release drug delivery. We support all phases of long acting injectable development from initial feasibility studies through FDA-approved clinical and commercial supply. Oakwood has 28 years of drug encapsulation experience using Chroniject™, our patented microsphere-based technology. Chroniject™ provides the ability to control particle size, customize release durations from weeks to years, and minimize residual solvents to achieve critical quality attributes.
The two main offerings we are showcasing for the event are:
- CDMO services for long acting injectables
- CMO services for sterile injectable manufacturing
Contact Us for More Information
The AAPS PharmaSci 360 conference covers a broad range of industry updates and innovation within the pharmaceutical industry, and we are happy to contribute to the event! If you aren’t able to attend, but still want to learn more about Oakwood Labs or what you missed at the conference, contact us today!
We look forward to discussing our technology and CDMO/CMO capabilities.
Oakwood Labs is happy to announce that we will be exhibiting and speaking at the upcoming Partnership Opportunities in Drug Delivery (PODD). The event is from October 27-28 at the Westin Copley Place Hotel in Boston, MA. Oakwood will have be exhibiting at booth #317. Also, Colin Spencer from our technology transfer team will be presenting on “Chroniject Technology: A Solution to Long Acting Injectable Formulation and Scale-Up Challenges” during Track 1A Injectable Formulations and Technologies on Monday, October 27th at 2:15pm If you would like to learn more about the event, please visit the following link: https://poddconference.com/
Company Overview
Oakwood Labs is a global leading CDMO in sustained release drug delivery. We support all phases of long acting injectable development from initial feasibility studies through FDA-approved clinical and commercial supply. Oakwood has 28 years of drug encapsulation experience using Chroniject™, our patented microsphere-based technology. Chroniject™ provides the ability to control particle size, customize release durations from weeks to years, and minimize residual solvents to achieve critical quality attributes.
The two main offerings we are showcasing for the event are:
- CDMO services for long acting injectables
- CMO services for sterile injectable manufacturing
Contact Us for More Information
The PODD conference covers a broad range of industry updates and innovation within the drug delivery field, and we are happy to contribute to the 15th event! If you aren’t able to attend, but still want to learn more about Oakwood Labs or what you missed at the conference, contact us today!
We look forward to discussing our technology and CDMO/CMO capabilities.
Oakwood Labs is happy to announce that we will be participating and exhibiting at the upcoming 2025 Contracting and Outsourcing Conference. The event is on September 18th at the Hyatt Regency Hotel in New Brunswick, New Jersey. Oakwood will be table 43. If you would like to learn more about the event, please visit the following link: https://conference.contractpharma.com/
Company Overview
Oakwood Labs is a global leading CDMO in sustained release drug delivery. We support all phases of long acting injectable development from initial feasibility studies through FDA-approved clinical and commercial supply. Oakwood has 28 years of drug encapsulation experience using Chroniject™, our patented microsphere-based technology. Chroniject™ provides the ability to control particle size, customize release durations from weeks to years, and minimize residual solvents to achieve critical quality attributes.
The two main offerings we are showcasing for the event are:
- CDMO services for long acting injectables
- CMO services for sterile injectable manufacturing
Contact Us for More Information
The Contract Pharma Conference covers the outsourcing of pharma services, and we are happy to contribute to the event! If you aren’t able to attend, but still want to learn more about Oakwood Labs or what you missed at the conference, contact us today!
We look forward to discussing our technology and CDMO/CMO capabilities.
Oakwood Labs is happy to announce that we will be participating and presenting at the upcoming Forum on Pharma: Building Better Injectables. The event goes from June 3-5 at the Ashland R&D site in Wilmington, Delaware. If you would like to learn more about the event, please visit the following link: https://solving.ashland.com/pharmaceutical/wilmington-injectable-form-0632025
Company Overview
Oakwood Labs is a global leader in sustained release drug delivery. We support all phases of long acting injectable development from initial feasibility studies through FDA-approved clinical and commercial supply. Oakwood has 28 years of drug encapsulation experience using Chroniject™, our patented microsphere-based technology. Chroniject™ provides the ability to control particle size, customize release durations from weeks to years, and minimize residual solvents to achieve critical quality attributes.
Oakwood will be presenting:
Dr. Tracy Richey (Senior Director of Technology) will be presenting on understanding advanced delivery formulation techniques.
Contact Us for More Information
The Forum on Pharma covers a wide range of topics, and we are happy to contribute to the event! If you aren’t able to attend, but still want to learn more about Oakwood Labs or what you missed at the conference, contact us today!
We look forward to discussing our technology and more.
Oakwood Labs is happy to announce that we will be exhibiting at Booth #748 at the upcoming 2025 Convention on Pharmaceutical Ingredients (CPHI) on May 20-22 in Philadelphia, Pennsylvania. If you would like to learn more about the event and register to attend, please visit the following link: https://www.cphi.com/americas/en/home.html
Company Overview
Oakwood Labs is a global leader in sustained release drug delivery. We support all phases of long acting injectable development from initial feasibility studies through FDA-approved clinical and commercial supply. Oakwood has 28 years of drug encapsulation experience using Chroniject™, our patented microsphere-based technology. Chroniject™ provides the ability to control particle size, customize release durations from weeks to years, and minimize residual solvents to achieve critical quality attributes.
Stop by Oakwood Lab’s Booth #748 to meet our team and learn more about how we can assist in the following areas:
- Long Acting Injectable Technology (CDMO)
- Feasibility studies
- Scale-up and optimization of formulation
- Manufacturing GLP toxicology batches
- Clinical trial manufacturing (Phase I, II, III)
- Contract Manufacturing (CMO)
- Technology Transfer
- GMP Registration and Validation batches
- Aseptic GMP commercial batch manufacturing
- ICH compliant stability testing
Contact Us for More Information
The CPHI Americas 2025 conference covers a wide range of topics, and we are happy to contribute to the event! If you aren’t able to attend, but still want to learn more about Oakwood Labs or what you missed at the conference, contact us today!
We look forward to discussing our technology and more.
Oakwood Labs is happy to announce that we will be exhibiting at Booth #2030 at the upcoming 2025 Association for Research in Vision and Ophthalmology (ARVO) on May 4-7 in Salt Lake City, Utah. If you would like to learn more about the event and register to attend, please visit the following link: https://www.arvo.org/annual-meeting/
Company Overview
Oakwood Labs is a global leader in sustained release drug delivery. We support all phases of long acting injectable development from initial feasibility studies through FDA-approved clinical and commercial supply. Oakwood has 27 years of drug encapsulation experience using Chroniject™, our patented microsphere-based technology. Chroniject™ provides the ability to control particle size, customize release durations from weeks to years, and minimize residual solvents to achieve critical quality attributes.
Stop by Oakwood Lab’s Booth #2030 to meet our team and learn more about how we can assist in the following areas:
- Long Acting Injectable Technology (CDMO)
- Feasibility studies
- Scale-up of formulation
- Manufacturing toxicology batches
- Clinical trial manufacturing (Phase I, II, III)
- Contract Manufacturing (CMO)
- Technology Transfer
- GMP Registration and Validation batches
- Aseptic GMP commercial batch manufacturing
- ICH compliant stability testing
Contact Us for More Information
The ARVO 2025 conference covers a wide range of topics, and we are happy to contribute to the event! If you aren’t able to attend, but still want to learn more about Oakwood Labs or what you missed at the conference, contact us today!
We look forward to discussing our technology and more.
Oakwood Labs is excited to participate in DCAT Week 2025, the premier global event held annually in New York City for companies engaged in the bio/pharmaceutical industry. This year’s DCAT Week is being held March 17–20, 2025.
Our team will be available on-site for business meetings. Please reach out today to book a meeting slot.
Oakwood Labs, Your Leading Sustained-Release Drug Manufacturer
Oakwood Labs is an experienced global CDMO partner that specializes in the development and manufacture of sustained-release injectable products. We use Chroniject™, which is a polymer microsphere-based drug delivery platform that offers various solutions such as:
- Compatibility with various molecule types
- Flexible release durations
- Applications in various therapeutic indications
With over 25 years of experience supplying sustained-release injectables, we’re dedicated to providing the best global pharmaceutical products.
Discover More About DCAT Week 2025
If you have any questions regarding DCAT Week 2025 or our capabilities at Oakwood Labs, feel free to contact us today.
Oakwood Labs will be exhibiting at Booth #31 and speaking at the upcoming 2024 PODD Conference taking place from October 28-29 in Boston. If you would like to learn more about the event and register to attend, please visit the following link: https://poddconference.com/
Company Overview
Oakwood Labs is a global leader in sustained release drug delivery. We support all phases of long acting injectable development from initial feasibility studies through FDA-approved clinical and commercial supply. Oakwood has 27 years of drug encapsulation experience using Chroniject™, our patented microsphere-based technology. Chroniject™ provides the ability to control particle size, customize release durations from weeks to years, and minimize residual solvents to achieve critical quality attributes.
Listen to Oakwood’s presentation during Day 1 on our Chroniject Technology: A Solution to Long Acting Injectable Formulation and Scale-Up Challenges
Colin Spencer, a project manager working within our technology transfer team will be presenting during Day 1 (Monday, October 28th) of the conference within the Track 1A: Injectable Formulations & Technologies at 2:30pm.
The presentation will include the following key points:
- Oakwood’s Chroniject technology provides a tunable long-acting injectable platform for a wide array of molecules and applications. Efficacious release profiles have been generated from as fast as two days to as long as one year.
- Oakwood’s Chroniject technology provides the platform for scale-up of the formulation process, allowing for the critical quality attributes of the long-acting injectable formulations to be maintained from initial feasibility batch sizes in the gram-scale to clinical and commercial batch sizes in the kilogram-scale.
Stop by Oakwood Lab’s Booth #31 to meet our team and learn more about how we can assist in the following areas:
- Long Acting Injectable Patented Technology (CDMO Services)
- Feasibility assessments
- Scale-up and optimization of lead formulation
- Manufacturing, characterization, and stability of R&D toxicology batches
- GMP Clinical trial manufacturing (Phase I, II, III)
- GMP Commercial manufacturing
- Contract Manufacturing (CMO Services)
- Technology Transfer
- GMP Registration and Validation batches
- Aseptic GMP commercial batch manufacturing
- ICH compliant stability testing
Contact Us for More Information
PODD 2024 conference covers a wide range of topics, and we are happy to contribute to the event! If you aren’t able to attend, but still want to learn more about Oakwood Labs or what you missed at the conference, contact us today!
We look forward to discussing our technology and more.
Oakwood Labs is happy to announce that we will be exhibiting at Booth #2610 at the upcoming 2024 AAPS PharmSci 360 on October 20-23 in Salt Lake City, Utah. If you would like to learn more about the event and register to attend, please visit the following link: https://www.aaps.org/pharmsci/annual-meeting
Company Overview
Oakwood Labs is a global leader in sustained release drug delivery. We support all phases of long acting injectable development from initial feasibility studies through FDA-approved clinical and commercial supply. Oakwood has 27 years of drug encapsulation experience using Chroniject™, our patented microsphere-based technology. Chroniject™ provides the ability to control particle size, customize release durations from weeks to years, and minimize residual solvents to achieve critical quality attributes.
Stop by Oakwood Lab’s Booth #2610 to meet our team and learn more about how we can assist in the following areas:
- Long Acting Injectable Technology (CDMO)
- Feasibility studies
- Scale-up of formulation
- Manufacturing toxicology batches
- Clinical trial manufacturing (Phase I, II, III)
- Contract Manufacturing (CMO)
- Technology Transfer
- GMP Registration and Validation batches
- Aseptic GMP commercial batch manufacturing
- ICH compliant stability testing
Contact Us for More Information
The AAPS 2024 conference covers a wide range of topics, and we are happy to contribute to the event! If you aren’t able to attend, but still want to learn more about Oakwood Labs or what you missed at the conference, contact us today!
We look forward to discussing our technology and more.
Oakwood Labs is happy to announce that we will be at the 2024 Drug Delivery and Formulation Summit on September 17-18 in San Diego. If you would like to learn more about the event and register to attend, please visit the following link: https://ddfsummit.com/DDF2024/en/page/home
Company Overview
Oakwood Labs is a global leader in sustained release drug delivery. We support all phases of long acting injectable development from initial feasibility studies through FDA-approved clinical and commercial supply. Oakwood has 25 years of drug encapsulation experience using Chroniject™, our patented microsphere-based technology. Chroniject™ provides the ability to control particle size, customize release durations from weeks to years, and minimize residual solvents to achieve critical quality attributes.
Stop by Oakwood Lab’s Booth #20 to meet our team and learn more about how we can assist in the following areas:
- Long Acting Injectable Technology
- Feasibility studies
- Scale-up of formulation
- Manufacturing toxicology batches
- Clinical trial manufacturing (Phase I, II, III)
- Contract Manufacturing
- Technology Transfer
- GMP Registration and Validation batches
- Aseptic GMP commercial batch manufacturing
- ICH compliant stability testing
Contact Us for More Information
The DDF 2024 conference covers a wide range of topics, and we are happy to contribute to the event! If you aren’t able to attend, but still want to learn more about Oakwood Labs or what you missed at the conference, contact us today!
We look forward to discussing our technology and more.